Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders. Results of a 2-year extension study.

Reyes M, Olah R, Csaba K, Augustyns I, Eerdekens M.

Eur Child Adolesc Psychiatry. 2006 Mar;15(2):97-104.

PMID:
16523250
[PubMed - indexed for MEDLINE]
2.

Risperidone in the management of disruptive behavior disorders.

Pandina GJ, Aman MG, Findling RL.

J Child Adolesc Psychopharmacol. 2006 Aug;16(4):379-92. Review.

PMID:
16958564
[PubMed - indexed for MEDLINE]
3.

Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.

Aman MG, Gharabawi GM; Special Topic Advisory Panel on Transitioning to Risperidone Therapy in Patients With Mental Retardation and Developmental Disabilities.

J Clin Psychiatry. 2004 Sep;65(9):1197-210. Review.

PMID:
15367046
[PubMed - indexed for MEDLINE]
4.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
5.

Risperidone in the management of agitation and aggression associated with psychiatric disorders.

De Deyn PP, Buitelaar J.

Eur Psychiatry. 2006 Jan;21(1):21-8. Epub 2006 Jan 18. Review.

PMID:
16414250
[PubMed - indexed for MEDLINE]
6.

Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.

Ipser J, Stein DJ.

Psychopharmacology (Berl). 2007 Mar;191(1):127-40. Epub 2006 Sep 16. Review.

PMID:
16983542
[PubMed - indexed for MEDLINE]
7.

Efficacy of risperidone in children with disruptive behavioural disorders.

Duhig MJ, Saha S, Scott JG.

J Paediatr Child Health. 2013 Jan;49(1):19-26. doi: 10.1111/j.1440-1754.2011.02200.x. Epub 2011 Nov 3. Review.

PMID:
22050179
[PubMed - indexed for MEDLINE]
8.

Long-term safety of risperidone.

Davidson M.

J Clin Psychiatry. 2001;62 Suppl 21:26-8. Review.

PMID:
11584985
[PubMed - indexed for MEDLINE]
9.

Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review.

Pringsheim T, Gorman D.

Can J Psychiatry. 2012 Dec;57(12):722-7. Review.

PMID:
23228230
[PubMed - indexed for MEDLINE]
10.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

PMID:
16796929
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk